Company Overview

Company name: Xceptor (CBD product, Cibidinol)
Also known as:
Description: Producer of proprietary CBD, Cibidinol, and other related products in Sheridan, United States, designed to increase the bioavailability of cannabidiol in consumable and topical products. The company’s services include development of proprietary processes for non-psychoactive compound found in hemp and cannabis, enabling customers seeking better health outcomes and quality of life to get access to a range to processed CBD and Cibidinol products in the market.
Year founded:
Parent company: CannAssist International
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.xceptorllc.com
Employees:
City: Sheridan
State: Wyoming
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by CannAssist International (OTC: CANN) for an undisclosed amount on July 12, 2018.
Number of active investors:
Profile last updated: 20-Sep-2018
Last known valuation:
Last known valuation date: